DBT completes genomic sequencing of 10,000 TB samples in India, aiming to understand drug-resistant TB and unique genomic ...

Currently, Kenya imports more than 70 percent of its essential medicines, mainly from India, China, and some European ...

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

The FDA cleared the investigational new drug (IND) application for EVM14. EVM14 is an off-the-shelf tumor-associated antigen ...

Danish drugmaker Novo Nordisk has secured the global rights to develop, manufacture and sell China-based United Laboratories ...

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Drugs and other treatments can be quite effective at killing cancer cells, yet many fall short as they struggle to penetrate ...

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders through targeted drug delivery.

By Mariam Sunny (Reuters) -Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G" weight-loss drug candidate in a deal worth up ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery ...